Combination of Lenvatinib and Pembrolizumab Is an Effective Treatment Option for Anaplastic and Poorly Differentiated Thyroid Carcinoma - Dierks, C; Seufert, J; Aumann, K (Thyroid: official journal of the American Thyroid Association, 2021)
et al.